blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2724156

EP2724156 - METHODS AND COMPOSITIONS FOR TREATMENT OF CANCER AND AUTOIMMUNE DISEASE [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  22.06.2018
Database last updated on 11.09.2024
FormerThe patent has been granted
Status updated on  14.07.2017
FormerGrant of patent is intended
Status updated on  05.03.2017
Most recent event   Tooltip17.07.2020Lapse of the patent in a contracting state
New state(s): AL		published on 19.08.2020  [2020/34]
Applicant(s)For all designated states
The Jackson Laboratory
600 Main Street
Bar Harbor, ME 04609 / US
[2014/18]
Inventor(s)01 / MILLS, Kevin David
41 Meadow Drive
Bar Harbor Maine 04609 / US
02 / HASHAM, Muneer Gulamhusien
106 Gary Moore Road
Ellsworth Maine 04605 / US
03 / MCPHEE, Caroline Gardner
13 Hodgdon Road
Seal Cove Maine 04674 / US
 [2014/18]
Representative(s)Kehoe, Laura Ellen, et al
Keltie LLP
No.1 London Bridge
London SE1 9BA / GB
[2017/33]
Former [2014/18]Kehoe, Laura Ellen, et al
Keltie LLP
Fleet Place House
2 Fleet Place
London EC4M 7ET / GB
Application number, filing date12730343.619.06.2012
[2017/33]
WO2012US43074
Priority number, dateUS201161501522P27.06.2011         Original published format: US 201161501522 P
[2014/18]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2013003112
Date:03.01.2013
Language:EN
[2013/01]
Type: A1 Application with search report 
No.:EP2724156
Date:30.04.2014
Language:EN
The application published by WIPO in one of the EPO official languages on 03.01.2013 takes the place of the publication of the European patent application.
[2014/18]
Type: B1 Patent specification 
No.:EP2724156
Date:16.08.2017
Language:EN
[2017/33]
Search report(s)International search report - published on:EP03.01.2013
ClassificationIPC:A61K31/145, G01N33/50, C07C309/51, C07C311/08, C07C311/14, C07C335/20, C12Q1/68
[2017/11]
CPC:
G01N33/5008 (EP,CN,US); C07C331/30 (US); A61K31/145 (EP,US);
A61K31/166 (CN); A61K31/18 (CN); A61K31/185 (CN);
A61P1/04 (EP); A61P1/16 (EP); A61P11/02 (EP);
A61P13/12 (EP); A61P17/02 (EP); A61P19/02 (EP);
A61P21/04 (EP); A61P25/00 (EP); A61P29/00 (EP);
A61P35/00 (EP); A61P35/02 (EP); A61P37/00 (EP);
A61P9/00 (EP); A61P9/14 (EP); C07C307/10 (US);
C07C309/51 (EP,CN,US); C07C311/08 (EP,CN,US); C07C311/14 (EP,CN,US);
C07C335/20 (EP,CN,US); C07C381/00 (CN); C07C2601/02 (EP,CN,US);
G01N2500/10 (EP,CN,US); G01N2800/52 (EP,CN,US) (-)
Former IPC [2014/18]G01N33/50, A61K31/00, A61K31/255, A61K31/26, A61P35/00, A61P35/02, A61P37/00
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2014/18]
Extension statesBANot yet paid
MENot yet paid
TitleGerman:VERFAHREN UND ZUSAMMENSETZUNGEN ZUR BEHANDLUNG VON KREBS UND AUTOIMMUNERKRANKUNGEN[2014/18]
English:METHODS AND COMPOSITIONS FOR TREATMENT OF CANCER AND AUTOIMMUNE DISEASE[2014/18]
French:PROCÉDÉS ET COMPOSITIONS POUR LE TRAITEMENT DU CANCER ET D'UNE MALADIE AUTO-IMMUNE[2014/18]
Entry into regional phase23.01.2014National basic fee paid 
23.01.2014Designation fee(s) paid 
23.01.2014Examination fee paid 
Examination procedure23.01.2014Examination requested  [2014/18]
30.09.2014Despatch of communication of loss of particular rights: Claims {1}
21.11.2014Amendment by applicant (claims and/or description)
01.06.2015Despatch of a communication from the examining division (Time limit: M06)
13.01.2016Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time
18.03.2016Reply to a communication from the examining division
08.06.2016Despatch of a communication from the examining division (Time limit: M04)
07.10.2016Reply to a communication from the examining division
06.03.2017Communication of intention to grant the patent
05.07.2017Fee for grant paid
05.07.2017Fee for publishing/printing paid
05.07.2017Receipt of the translation of the claim(s)
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  01.06.2015
Opposition(s)17.05.2018No opposition filed within time limit [2018/30]
Request for further processing for:The application is deemed to be withdrawn due to failure to reply to the examination report
18.03.2016Request for further processing filed
18.03.2016Full payment received (date of receipt of payment)
Request granted
01.04.2016Decision despatched
21.11.2014Request for further processing filed
21.11.2014Full payment received (date of receipt of payment)
Request granted
03.12.2014Decision despatched
21.11.2014Request for further processing filed
21.11.2014Full payment received (date of receipt of payment)
Request granted
03.12.2014Decision despatched
Fees paidRenewal fee
31.03.2014Renewal fee patent year 03
19.06.2015Renewal fee patent year 04
27.06.2016Renewal fee patent year 05
27.06.2017Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU19.06.2012
AL16.08.2017
AT16.08.2017
CY16.08.2017
CZ16.08.2017
DK16.08.2017
EE16.08.2017
ES16.08.2017
FI16.08.2017
HR16.08.2017
IT16.08.2017
LT16.08.2017
LV16.08.2017
MC16.08.2017
MK16.08.2017
NL16.08.2017
PL16.08.2017
PT16.08.2017
RO16.08.2017
RS16.08.2017
SE16.08.2017
SI16.08.2017
SK16.08.2017
SM16.08.2017
TR16.08.2017
BG16.11.2017
NO16.11.2017
GR17.11.2017
IS16.12.2017
[2020/34]
Former [2020/31]HU19.06.2012
AT16.08.2017
CY16.08.2017
CZ16.08.2017
DK16.08.2017
EE16.08.2017
ES16.08.2017
FI16.08.2017
HR16.08.2017
IT16.08.2017
LT16.08.2017
LV16.08.2017
MC16.08.2017
MK16.08.2017
NL16.08.2017
PL16.08.2017
PT16.08.2017
RO16.08.2017
RS16.08.2017
SE16.08.2017
SI16.08.2017
SK16.08.2017
SM16.08.2017
TR16.08.2017
BG16.11.2017
NO16.11.2017
GR17.11.2017
IS16.12.2017
Former [2020/30]HU19.06.2012
AT16.08.2017
CZ16.08.2017
DK16.08.2017
EE16.08.2017
ES16.08.2017
FI16.08.2017
HR16.08.2017
IT16.08.2017
LT16.08.2017
LV16.08.2017
MC16.08.2017
NL16.08.2017
PL16.08.2017
PT16.08.2017
RO16.08.2017
RS16.08.2017
SE16.08.2017
SI16.08.2017
SK16.08.2017
SM16.08.2017
TR16.08.2017
BG16.11.2017
NO16.11.2017
GR17.11.2017
IS16.12.2017
Former [2020/27]HU19.06.2012
AT16.08.2017
CZ16.08.2017
DK16.08.2017
EE16.08.2017
ES16.08.2017
FI16.08.2017
IT16.08.2017
LT16.08.2017
LV16.08.2017
MC16.08.2017
NL16.08.2017
PL16.08.2017
PT16.08.2017
RO16.08.2017
RS16.08.2017
SE16.08.2017
SI16.08.2017
SK16.08.2017
SM16.08.2017
TR16.08.2017
BG16.11.2017
NO16.11.2017
GR17.11.2017
IS16.12.2017
Former [2020/16]AT16.08.2017
CZ16.08.2017
DK16.08.2017
EE16.08.2017
ES16.08.2017
FI16.08.2017
IT16.08.2017
LT16.08.2017
LV16.08.2017
MC16.08.2017
NL16.08.2017
PL16.08.2017
RO16.08.2017
RS16.08.2017
SE16.08.2017
SI16.08.2017
SK16.08.2017
SM16.08.2017
TR16.08.2017
BG16.11.2017
NO16.11.2017
GR17.11.2017
IS16.12.2017
Former [2019/15]AT16.08.2017
CZ16.08.2017
DK16.08.2017
EE16.08.2017
ES16.08.2017
FI16.08.2017
IT16.08.2017
LT16.08.2017
LV16.08.2017
MC16.08.2017
NL16.08.2017
PL16.08.2017
RO16.08.2017
RS16.08.2017
SE16.08.2017
SI16.08.2017
SK16.08.2017
SM16.08.2017
BG16.11.2017
NO16.11.2017
GR17.11.2017
IS16.12.2017
Former [2018/39]AT16.08.2017
CZ16.08.2017
DK16.08.2017
EE16.08.2017
ES16.08.2017
FI16.08.2017
IT16.08.2017
LT16.08.2017
LV16.08.2017
NL16.08.2017
PL16.08.2017
RO16.08.2017
RS16.08.2017
SE16.08.2017
SI16.08.2017
SK16.08.2017
SM16.08.2017
BG16.11.2017
NO16.11.2017
GR17.11.2017
IS16.12.2017
Former [2018/24]AT16.08.2017
CZ16.08.2017
DK16.08.2017
EE16.08.2017
ES16.08.2017
FI16.08.2017
IT16.08.2017
LT16.08.2017
LV16.08.2017
NL16.08.2017
PL16.08.2017
RO16.08.2017
RS16.08.2017
SE16.08.2017
SK16.08.2017
SM16.08.2017
BG16.11.2017
NO16.11.2017
GR17.11.2017
IS16.12.2017
Former [2018/23]AT16.08.2017
CZ16.08.2017
DK16.08.2017
EE16.08.2017
ES16.08.2017
FI16.08.2017
LT16.08.2017
LV16.08.2017
NL16.08.2017
PL16.08.2017
RO16.08.2017
RS16.08.2017
SE16.08.2017
SK16.08.2017
BG16.11.2017
NO16.11.2017
GR17.11.2017
IS16.12.2017
Former [2018/21]AT16.08.2017
CZ16.08.2017
DK16.08.2017
ES16.08.2017
FI16.08.2017
LT16.08.2017
LV16.08.2017
NL16.08.2017
PL16.08.2017
RS16.08.2017
SE16.08.2017
BG16.11.2017
NO16.11.2017
GR17.11.2017
IS16.12.2017
Former [2018/12]AT16.08.2017
ES16.08.2017
FI16.08.2017
LT16.08.2017
LV16.08.2017
NL16.08.2017
PL16.08.2017
RS16.08.2017
SE16.08.2017
BG16.11.2017
NO16.11.2017
GR17.11.2017
IS16.12.2017
Former [2018/11]AT16.08.2017
ES16.08.2017
FI16.08.2017
LT16.08.2017
NL16.08.2017
PL16.08.2017
RS16.08.2017
SE16.08.2017
BG16.11.2017
NO16.11.2017
GR17.11.2017
IS16.12.2017
Former [2018/10]AT16.08.2017
FI16.08.2017
LT16.08.2017
NL16.08.2017
RS16.08.2017
SE16.08.2017
NO16.11.2017
Former [2018/09]FI16.08.2017
LT16.08.2017
NL16.08.2017
SE16.08.2017
NO16.11.2017
Former [2018/08]FI16.08.2017
LT16.08.2017
NL16.08.2017
NO16.11.2017
Former [2018/07]LT16.08.2017
NO16.11.2017
Cited inInternational search[A]WO03039557  (UNIV CALIFORNIA [US], et al) [A] 1-27,32-44,73-99,104-115 * figures 1-9; claims 1-6,16-31 *;
 [A]WO2004021987  (MERCK & CO INC [US], et al) [A] 1-27,32-44,73-99,104-115 * claims 1,3,5 *;
 [XD]  - T. ISHIDA ET AL, "DIDS, a chemical compound that inhibits RAD51-mediated homologous pairing and strand exchange", NUCLEIC ACIDS RESEARCH, (20090330), vol. 37, no. 10, doi:10.1093/nar/gkp200, ISSN 0305-1048, pages 3367 - 3376, XP055036178 [XD] 1 * abstract * * figures 1,2 * * Relevant for non unity *

DOI:   http://dx.doi.org/10.1093/nar/gkp200
 [XI]  - MUNEER G HASHAM ET AL, "Widespread genomic breaks generated by activation-induced cytidine deaminase are prevented by homologous recombination", NATURE IMMUNOLOGY, (20100725), vol. 11, no. 9, doi:10.1038/ni.1909, ISSN 1529-2908, pages 820 - 826, XP055036263 [X] 1-9,21,22,34-40,44,73-81,93,94,106-112 * abstract * * page 821, column 1, line 16, paragraph 1 - line 21 * * page 821, column 1, paragraph 2 - column 2, paragraph 1 * [I] 10-22,32,33,41-43,82-94,104,105,113-115

DOI:   http://dx.doi.org/10.1038/ni.1909
 [A]  - HAITAO LI ET AL, "2,3',4,4',5'-Pentamethoxy-trans-stilbene, a resveratrol derivative, inhibits colitis-associated colorectal carcinogenesis in mice", BRITISH JOURNAL OF PHARMACOLOGY, (20100701), vol. 160, no. 6, doi:10.1111/j.1476-5381.2010.00785.x, ISSN 0007-1188, pages 1352 - 1361, XP055036726 [A] 1-27,32-44,73-99,104-115 * abstract *

DOI:   http://dx.doi.org/10.1111/j.1476-5381.2010.00785.x
 [A]  - KIM Y H ET AL, "Piceatannol, a stilbene present in grapes, attenuates dextran sulfate sodium-induced colitis", INTERNATIONAL IMMUNOPHARMACOLOGY, ELSEVIER, AMSTERDAM, NL, vol. 8, no. 12, doi:10.1016/J.INTIMP.2008.08.003, ISSN 1567-5769, (20081210), pages 1695 - 1702, (20080904), XP025473993 [A] 1-27,32-44,73-99,104-115 * abstract * * figure 1a *

DOI:   http://dx.doi.org/10.1016/j.intimp.2008.08.003
 [A]  - BADGER A M ET AL, "Idoxifene, a novel selective estrogen receptor modulator, is effective in a rat model of adjuvant-induced arthritis", JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, THE AMERICAN SOCIETY FOR PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, US, (19991201), vol. 291, no. 3, ISSN 0022-3565, pages 1380 - 1386, XP002372594 [A] 1-27,32-44,73-99,104-115 * abstract * * figure 1 *
 [A]  - JIN-MING HWANG ET AL, "Reduction of anion exchanger 2 expression induces apoptosis of human hepatocellular carcinoma cells", MOLECULAR AND CELLULAR BIOCHEMISTRY, KLUWER ACADEMIC PUBLISHERS, BO, (20090218), vol. 327, no. 1-2, ISSN 1573-4919, pages 135 - 144, XP019684248 [A] 1-27,32-44,73-99,104-115 * abstract *
 [A]  - CHUNG-JUNG LIU ET AL, "Anion exchanger inhibitor DIDS induces human poorly-differentiated malignant hepatocellular carcinoma HA22T cell apoptosis", MOLECULAR AND CELLULAR BIOCHEMISTRY, KLUWER ACADEMIC PUBLISHERS, BO, (20071016), vol. 308, no. 1-2, ISSN 1573-4919, pages 117 - 125, XP019578300 [A] 1-27,32-44,73-99,104-115 * abstract *
 [A]  - HORVAT B ET AL, "Tumour cell proliferation is abolished by inhibitors of Na<+>H<+> and HCO3<->Cl<-> exchange", EUROPEAN JOURNAL OF CANCER, PERGAMON PRESS, OXFORD, GB, vol. 29, no. 1, doi:10.1016/0959-8049(93)90591-3, ISSN 0959-8049, (19930101), pages 132 - 137, (19930101), XP026201861 [A] 1-27,32-44,73-99,104-115 * abstract *

DOI:   http://dx.doi.org/10.1016/0959-8049(93)90591-3
 [A]  - MONA LEUENBERGER ET AL, "AID protein expression in chronic lymphocytic leukemia/small lymphocytic lymphoma is associated with poor prognosis and complex genetic alterations", MODERN PATHOLOGY, (20100201), vol. 23, no. 2, doi:10.1038/modpathol.2009.156, ISSN 0893-3952, pages 177 - 186, XP055036781 [A] 1-27,32-44,73-99,104-115 * abstract *

DOI:   http://dx.doi.org/10.1038/modpathol.2009.156
by applicantUS548257
 US3387050
 US3773919
 US4326055
 US4366241
 US4376110
 US4426330
 US4517288
 US4534899
 US4723034
 US4723028
 WO8804300
 WO8804924
 US4837168
 US4837028
 US4892949
 WO9004384
 WO9011364
 US4965343
 US4996237
 WO9105545
 US5013556
 US5045694
 EP0454461
 WO9117271
 US5068300
 WO9201047
 WO9202532
 US5093246
 US5118937
 US5213804
 US5225212
 WO9322461
 US5264221
 EP0445131
 US5322770
 WO9420073
 US5356633
 EP0496813
 US5430062
 JPH07225558
 EP0684315
 WO9610391
 US5525632
 US5540935
 US5543152
 US5556948
 US5561122
 US5563298
 WO9631622
 JPH08301831
 US5583973
 WO9640062
 US5589506
 WO9700478
 US5612894
 WO9710365
 WO9713499
 US5665710
 US5670356
 US5719060
 US5731353
 JPH1081673
 EP0834575
 EP0834576
 WO9830883
 US5837832
 US5849954
 WO9859361
 US6022998
 US6043082
 US6146885
 US6177220
 US6191105
 US6218108
 US6268490
 US6316198
 US6329209
 WO0214860
 US6365418
 US6379897
 US6451536
 US2002137698
 US2002155493
 WO02086096
 US2003013208
 US2003017515
 US2003027780
 US2003077616
 US6562834
 US2003129665
 US2003134304
 US2003157485
 WO03070726
 US6618679
 US2003199001
 US6649595
 US2003215858
 US6664377
 US6670461
 US2004014959
 US6747014
 US2004143023
 US2004147788
 US6794499
 WO2005016919
 US6887906
 US6913880
 US6977295
 US6998484
 US7053195
 US7063860
 US7070802
 US7157099
 WO2007026157
 US2007213292
 US2007276172
 US7319933
 US7321050
 US2008071364
 EP1946757
 WO2009036297
 US7655696
 WO2010019898
 US7714161
 US7781580
 US7820848
 US8101804
    - ISHIDA, T. ET AL., NUCLEIC ACIDS RES, (2009), vol. 37, no. 10, pages 3367 - 76
    - LALLY ET AL., CANCER RES, (2007), vol. 67, page 8791
    - VOLPI; BRIDGER, BIOTECHNIQUES, vol. 45, no. 4, pages 385 - 409
    - RAKIMAN ET AL., ADVANCE BIOTECH, (2008), pages 39 - 42
    - The Merck Manual of Diagnosis and Therapy, 18th Edition,, MERCK RESEARCH LABORATORIES, (2006), ISBN 0-911910-18-2
    - ROBERT S. PORTER ET AL., The Encyclopedia of Molecular Biology, BLACKWELL SCIENCE LTD., (1994), ISBN 0-632-02182-9
    - Molecular Biology and Biotechnology: a Comprehensive Desk Reference, VCH PUBLISHERS, INC., (1995), ISBN 1-56081-569-8
    - BENJAMIN LEWIN, Genes IX, JONES & BARTLETT PUBLISHING, (2007), ISBN 9780763740634
    - "Methods in Enzymology", J. N. ABELSON, M. I. SIMON, G. B. FIELDS, Solid-Phase Peptide Synthesis, ACADEMIC PRESS, (1997), vol. 289, ISBN 9780121821906
    - S. L. BERGER AND A. R. KIMMEL, Methods in Enzymology: Guide to Molecular Cloning Techniques, ACADEMIC PRESS INC., (1987), vol. 152
    - JOHN E. COLIGAN, ET. AL., E, Current Protocols in Protein Science, JOHN WILEY AND SONS, INC.
    - JUAN S. BONIFACINO ET. AL., Current Protocols in Cell Biology (CPCB, JOHN WILEY AND SONS, INC.
    - JENNIE P. MATHER AND DAVID BARNES, Animal Cell Culture Methods (Methods in Cell Biology, ACADEMIC PRESS, (1998), vol. 57
    - LANZAVECCHIA ET AL., EUR. J. IMMUNOL., (1987), vol. 17, page 105
    - HUSTON ET AL., PROC. NATL. ACAD. SCI. U.S.A., (1988), vol. 85, pages 5879 - 5883
    - BIRD ET AL., SCIENCE, (1988), vol. 242, pages 423 - 426
    - HARMSEN ET AL., APPL. MICROBIOL. BIOTECHNOL., (2007), vol. 77, no. 1, pages 13 - 22
    - HOLT ET AL., TRENDS IN BIOTECHNOLOGY, (2003), vol. 21, no. 11, pages 484 - 490
    - HUNKAPILLER; HOOD, NATURE, (1986), vol. 323, pages 15 - 16
    - BINZ ET AL., NAT BIOTECHNOL, (2005), pages 1257 - 6
    - LEE ET AL., PROC NATL ACAD SCI USA, (2010), vol. 107, no. 21, pages 9567 - 71
    - GEBAUER; SKERRA, CURR OPIN CHEM BIOL., (2009), vol. 13, no. 3, pages 245 - 255
    - BATZER ET AL., NUCLEIC ACID RES., (1991), vol. 19, page 5081
    - OHTSUKA ET AL., J. BIOL. CHEM., (1985), vol. 260, pages 2605 - 2608
    - ROSSOLINI ET AL., MOL. CELL. PROBES, (1994), vol. 8, pages 91 - 98
    - Remington's Pharmaceutical Sciences, MACK PRINTING COMPANY, (1990), pages 1289 - 1329
    - BERGE ET AL., "Pharmaceutical Salts", J. PHARM. SCI., (1977), vol. 66, pages 1 - 19
    - MANIS ET AL., TRENDS IMMUNOL, (2002), vol. 23, pages 31 - 39
    - CHAUDHURI; ALT, NAT REV IMMUNOL, (2004), vol. 4, pages 541 - 552
    - LONGERICH ET AL., CURR OPIN IMMUNOL, (2006), vol. 18, pages 164 - 174
    - CHAUDHURI ET AL., ADV IMMUNOL, (2007), vol. 94, pages 157 - 214
    - CROUCH ET AL., J EXP MED, (2007), vol. 204, pages 1145 - 1156
    - MURAMATSU ET AL., J BIOL CHEM, (1999), vol. 274, pages 18470 - 6
    - LONGERICH ET AL., CURR OPIN IMMUNOL, (2006), vol. 18, pages 164 - 176
    - MILLS ET AL., IMMUNOL REV, (2003), vol. 194, pages 77 - 95
    - LIU, M. ET AL., NATURE, (2008), vol. 451, pages 841 - 845
    - LIU; SCHATZ, TRENDS IMMUNOL., (2009), vol. 30, pages 173 - 181
    - PEREZ-DURAN ET AL., CARCINOGENESIS, (2007), vol. 28, no. 12, pages 2427 - 33
    - ROBBIANI ET AL., MOL CELL, (2009), vol. 36, no. 4, pages 631 - 41
    - PASQUALUCCI ET AL., NAT. GENET., (2008), vol. 40, pages 108 - 112
    - MUTO ET AL., PROC. NATL. ACAD. SCI. USA, (2006), vol. 103, pages 2752 - 2757
    - OKAZAKI ET AL., J. EXP. MED., (2003), vol. 197, pages 1173 - 1181
    - SHEN ET AL., MOL. IMMUNOL., (2008), vol. 45, pages 1883 - 1892
    - KOVALCHUK, J. EXP. MCD., (2007), vol. 204, pages 2989 - 3001
    - RAMIRO ET AL., J. EXP. MED., (2004), vol. 200, pages 1103 - 1110
    - KUPPERS, ONCOGENE, (2005), vol. 20, pages 5580 - 5594
    - HANCER ET AL., LEUK LYMPHOMA., (201101), vol. 52, no. 1, pages 79 - 84
    - HEINTEL ET AL., LEUKEMIA., (200404), vol. 18, no. 4, pages 756 - 62
    - MAO ET AL., BR J DERMATOL, (2001), vol. 145, pages 117 - 122
    - CHAUDHURI ET AL., NATURE, (2004), vol. 430, pages 992 - 8
    - GREEVE ET AL., BLOOD, (2003), vol. 1010, pages 3574 - 3580
    - FELDHAHN ET AL., J EXP MED, (2007), vol. 204, pages 1157 - 1166
    - KOTANI ET AL., PNAS USA, (2007), vol. 104, pages 1616 - 1620
    - ENGCLS, APPL IMMUNOHISTOCHCM MOL MORPHOL, (2008), vol. 16, pages 521 - 529
    - KLEMM ET AL., CANCER CELL, (2009), vol. 6, pages 232 - 245
    - PALACIOS ET AL., BLOOD, (2010), vol. 115, no. 22, pages 4488 - 4496
    - LEUENBERGER ET AL., MOD PATHOL, (2009), vol. 32, pages 177 - 186
    - GRUBER ET AL., CANCER RES, (2010), vol. 70, pages 7411 - 7420
    - MARUSAWA, INT J BIOCHEM CELL BIOL., (2008), vol. 40, pages 399 - 402
    - HARDIANTI ET AL., LEUKEMIA, (2004), vol. 18, pages 826 - 831
    - SHIKATA ET AL., CANCER SCI., (2012), vol. 103, no. 3, pages 415 - 21
    - QIU ET AL., MOD PATHOL, (2012), vol. 25, no. 1, pages 36 - 45
    - BORCHERT ET AL., BMC CANCER, (2011), vol. 11, page 347
    - MARUSAWA ET AL., ADV IMMUNOL, (2011), vol. 111, pages 109 - 41
    - ZHANG ET AL., HUM PATHOL, (2012), vol. 43, no. 3, pages 423 - 34
    - KOMORI ET AL., HCPATOLOGY, (2008), vol. 47, no. 3, pages 888 - 896
    - HOCKLEY, LEUKEMIA, (2010), vol. 24, no. 5, pages 1084 - 6
    - NAKAMURA ET AL., BR J DERMATOL., (2011), vol. 165, no. 2, pages 437 - 9
    - XU ET AL., SCAND. J. IMMUNOL., (2009), vol. 296, pages 2033 - 6
    - WHITE ET AL., AUTOIMMUNITY, (2011), vol. 44, no. 8, pages 585 - 98
    - KLEIN, DNA REPAIR, (2008), vol. 7, pages 686 - 93
    - SAN FILIPPO ET AL., ANNUAL REVIEW OF BIOCHEMISTRY, (2008), vol. 77, pages 229 - 257
    - LI ET AL., PNAS, (1996), vol. 93, pages 10222 - 7
    - YOKOYAMA ET AL., J BIOL CHEM., (2003), vol. 278, no. 4, pages 2767 - 72
    - THACKER, TRENDS GENET., (1999), vol. 15, pages 166 - 168
    - SCHILD D ET AL., J. BIOL. CHEM., (2000), vol. 275, pages 16443 - 16449
    - MODESTI ET AL., MOL CELL, (2007), vol. 28, pages 468 - 481
    - DUNLOP ET AL., J BIOL CHEM, (2012), vol. 6, no. 287, pages 12343 - 7
    - MAZINA ET AL., J BIOL CHEM, (20111206), vol. 287, no. 15, pages 11820 - 32
    - COUSINEAU ET AL., CANCER RES, (2005), vol. 65, pages 11384 - 91
    - YANG ET AL., J BIOL CHEM, (2002), vol. 277, pages 31980 - 7
    - BROSH ET AL., J BIOL CHEM, (2000), vol. 275, pages 23500 - 8
    - ROSSI ET AL., DNA REPAIR, (2010), vol. 9, pages 796 - 804
    - THACKER, BIOCHIMIE, (1999), vol. 81, pages 77 - 85
    - BRAYBROOKE ET AL., J BIOL CHEM, (2000), vol. 275, pages 29110 - 6
    - DEANS ET AL., EMBO J, (2000), vol. 19, pages 6675 - 6685
    - JOHNSON, NATURE, (1999), vol. 401, pages 397 - 9
    - DOHNER ET AL., BLOOD, (1998), vol. 92, pages 4031 - 5
    - SIMMONS ET AL., LEUKEMIA, (2002), vol. 16, pages 2408 - 2416
    - LIU ET AL., J BIOMED BIOTECHNOL, (2002), vol. 2, pages 106 - 113
    - DEANS ET AL., CANCER RES, (2003), vol. 63, pages 8181 - 7
    - CADDLE ET AL., MOL. CELL. BIOL., (2008), vol. 28, pages 2295 - 2303
    - ORII ET AL., PNAS, (2006), vol. 103, pages 10017 - 10022
    - ADAM ET AL., DNA REPAIR (AMST., (2007), vol. 6, pages 224 - 234
    - HASHAM ET AL., NATURE IMMUNOLOGY, (2010), vol. 11, no. 9, pages 820 - 826
    - ROBERTI ET AL., J. MED. CHEM, (2003), vol. 46, pages 3546 - 54
    - BADERSCHNEIDER; WINTERHALTER, J OF AGRICULTURAL AND FOOD CHEM, (2000), vol. 48, pages 2681 - 6
    - HILLIS; ISHIKURA, JOURNAL OF CHROMATOGRAPHY A, (1968), vol. 32, pages 323 - 336
    - KIM ET AL., J MED CHEM, (2002), vol. 45, pages 160 - 4
    - YOUNG ET AL., J AM CHEM SOC, (1972), vol. 94, pages 3976 - 81
    - ILIYA ET AL., PHYTOCHEMISTRY, (2003), vol. 62, pages 601 - 6
    - AGUAMAH ET AL., PHYTOCHEMISTRY, (1981), vol. 20, pages 1381 - 3
    - KIM ET AL., J BIOL CHEM, (2002), vol. 277, pages 16340 - 4
    - HOUSTON TX, MOL CANCER THER, (2009), vol. 8, no. 10, pages 2894 - 2902
    - ROGAKOU ET AL., J BIOL CHEM, (1998), vol. 273, pages 5858 - 5868
    - ROTHKAMM; L6BRICH, PROC NATL ACAD SCI USA, (2003), vol. 100, no. 9, pages 5057 - 5062
    - RCDON, AGING, (2011), vol. 3, no. 2, pages 168 - 74
    - RAKIMAN ET AL., ADVANCED BIOTECH, (2008), page 39
    - ORLOW ET AL., J. CLIN. ONCOL., (2008), vol. 26, pages 3560 - 3566
    - MULLER ET AL., INTERNATIONAL JOURNAL OF RADIATION BIOLOGY, (1994), vol. 65, pages 315 - 319
    - FAIRBAIRN ET AL., MUTATION RESEARCH/REVIEWS IN GENETIC TOXICOLOGY, (1995), vol. 339, pages 37 - 59
    - ISHIDA ET AL., NUCLEIC ACIDS RES, (2009), vol. 37, pages 3367 - 3376
    - KOSHKIN A.A., TETRAHEDRON, (1998), vol. 54, pages 3607 - 3630
    - OBIKA S., TETRAHEDRON LETT., (1998), vol. 39, pages 5401 - 5404
    - WENGEL J., ACC. CHEM. RES., (1999), vol. 32, pages 301 - 310
    - BRAASCH D.A.; COREY, D.R., CHEM. BIOL., (2001), vol. 8, pages 1 - 7
    - CRINELLI R., NUCLEIC ACIDS RES., (2002), vol. 30, pages 2435 - 2443
    - ISHIDA, NUCLEIC ACIDS RES, (2009), vol. 37, pages 3367 - 3376
    - BEVAN ET AL., TRENDS IN BIOTECHNOLOGY, (1995), vol. 13, pages 115 - 122
    - ECKER; CROOKE, BIOTECHNOLOGY (NY, (1995), vol. 13, pages 351 - 360
    - HODGSON, BIOTECHNOLOGY (NY, (1992), vol. 10, pages 973 - 980
    - METHODS IN MOLECULAR BIOLOGY, (19950927), vol. 49, pages 229 - 238
    - CHIRGWIN ET AL., BIOCHEMISTRY, (1979), vol. 18, pages 5294 - 5299
    - DULAC, C., CURR. TOP. DEV. BIOL., (1998), vol. 36, page 245
    - JENA ET AL., J. IMMUNOL. METHODS, (1996), vol. 190, page 199
    - DING ET AL., J AM. CHEM. SOC., (2002), vol. 124, pages 1594 - 1596
    - LYNN ET AL., J. AM. CHEM. SOC., (2001), vol. 123, pages 8155 - 8156
    - SCHIFFELERS; STORM, EXPERT OPIN DRUG DELIV., (200605), vol. 3, no. 3, pages 445 - 54
    - HUGHES ET AL., METHODS MOL BIOL., (2010), vol. 605, pages 445 - 59
    - SARVER ET AL., SCIENCE, (1990), vol. 247, pages 1222 - 1225
    - HASELOFF; GERLACH, NATURE, (1988), vol. 334, pages 585 - 591
    - ZAUG ET AL., SCIENCE, (1984), vol. 224, pages 574 - 578
    - ZAUG ET AL., SCIENCE, (1986), vol. 231, pages 470 - 475
    - ZAUG ET AL., NATURE, (1986), vol. 324, pages 429 - 433
    - BEEN ET AL., CELL, (1986), vol. 47, pages 207 - 216
    - LIM, GENES & DEVELOPMENT, (2003), vol. 17, pages 991 - 1008
    - LIM ET AL., SCIENCE, (2003), vol. 299, page 1540
    - LEE; AMBROS, SCIENCE, (2001), vol. 294, page 862
    - LAU ET AL., SCIENCE, (2001), vol. 294, pages 858 - 861
    - LAGOS-QUINTANA ET AL., CURRENT BIOLOGY, (2002), vol. 12, pages 735 - 739
    - LAGOS QUINTANA ET AL., SCIENCE, (2001), vol. 294, pages 853 - 857
    - LAGOS-QUINTANA ET AL., RNA, (2003), vol. 9, pages 175 - 179
    - BARTEL ET AL., CELL, (2004), vol. 116, pages 281 - 297
    - HUNKAPILLCR; HOOD, NATURE, (1986), vol. 323, pages 15 - 16
    - KOHLER; MILSTEIN, EUR, J. IMMUNOL., (1976), vol. 6, pages 511 - 519
    - HUSE ET AL., SCIENCE, (1989), vol. 246, pages 1275 - 1281
    - VAN HOLDE, K. E., Physical Bio-chemistry, PRENTICE-HALL, (1971), pages 221 - 239
    - SIMON ET AL., TRENDS IN GENETICS, (1998), vol. 14, page 272
    - EMMERT-BUCK ET AL., SCIENCE, (1996), vol. 274, pages 998 - 1001
    - GIBSON ET AL., GENOME RESEARCH, (1996), vol. 6, pages 995 - 1001
    - HEID ET AL., GENOME RESEARCH, (1996), vol. 6, pages 986 - 994
    - GIBSON ET AL., GENOME RES., (1996), vol. 10, pages 995 - 1001
    - HEID ET AL., GENOME RES., (1996), vol. 10, pages 986 - 994
    - R. L. MARSHALL ET AL., PCR METHODS AND APPLICATIONS, (1994), vol. 4, pages 80 - 84
    - WU; WALLACE, GENOMICS, (1989), vol. 4, page 560
    - LANDEGREN ET AL., SCIENCE, (1988), vol. 241, page 1077
    - GUATELLI ET AL., PNAS USA, (1990), vol. 87, page 1874
    - KWOH ET AL., PNAS USA, (1989), vol. 86, page 1173
    - G. T. WALKER ET AL., CLIN. CHEM., (1996), vol. 42, pages 9 - 13
    - CLINICAL CHEMISTRY, (2006), vol. 52, pages 1855 - 1863
    - PNAS USA, (1990), vol. 87, pages 1874 - 1878
    - NATURE, (1991), vol. 350, no. 6313, pages 91 - 92
    - MOLLASALEHI ET AL., ANAL BIOCHEM, (2012), vol. 425, pages 91 - 95
    - RYAN ET AL., BIOTECHNIQUES, (2008), vol. 45, no. 1, pages 81 - 94
    - WANG Z ET AL., NATURE REVIEWS GENETICS, (2009), vol. 10, no. 1, pages 57 - 63
    - MAHER CA ET AL., NATURE, (2009), vol. 458, no. 7234, pages 97 - 101
    - GUATELLI ET AL., PROC. NATL. ACAD. SCI. USA, (1990), vol. 87, page 1874
    - KWOH, PROC. NATL. ACAD. SCI. USA, (1989), vol. 86, page 1173
    - SCHENA ET AL., SCIENCE, (1995), vol. 20, pages 467 - 470
    - GERHOLD ET AL., TRENDS IN BIOCHEM. SCI., (1999), vol. 24, pages 168 - 173
    - LENNON ET AL., DRUG DISCOVERY TODAY, (2000), vol. 5, pages 59 - 65
    - OELLERICH, M., J. CLIN. CHEM. CLIN. BIOCHEM., (1984), vol. 22, pages 895 - 904
    - STEMMANN O.; ZOU H.; GERBER S. A.; GYGI S. P.; KIRSCHNER M. W., "Dual inhibition of sister chromatid separation at metaphase", CELL, (20011214), vol. 107, pages 715 - 726
    - KESHISHIAN ET AL., MOLECULAR & CELLULAR PROTEOMICS, (2007), vol. 6.12, pages 2212 - 2229
    - TOWBIN ET AL., PROC. NAT. ACAD. SCI., (1979), vol. 76, page 4350
    - LI ET AL., TIBTECH, (2000), vol. 18, pages 151 - 160
    - ROWLEY ET AL., METHODS, (2000), vol. 20, pages 383 - 397
    - KUSTER; MANN, CURR. OPIN. STRUCTURAL BIOL., (1998), vol. 8, pages 393 - 400
    - CHAIT ET AL., SCIENCE, (1993), vol. 262, pages 89 - 92
    - KCOUGH, PROC. NATL. ACAD. SCI. USA., (1999), vol. 96, pages 7131 - 6
    - BERGMAN, EXS, (2000), vol. 88, pages 133 - 44
    - Kirk-Othmer Encyclopedia of Chemical Technology, 4.sup.th ed., JOHN WILEY & SONS, (1995), vol. 15, pages 1071 - 1094
    - VOLPI; BRIDGER, BIOTECHNIQUES, (200810), vol. 45, no. 4, pages 385 - 409
    - SCHULTZ ET AL., JOURNAL OF CELL BIOLOGY, (2000), vol. 151, pages 1381 - 1390
    - HOCHEGGER; TAKEDA, SUBCELL BIOCHEM., (2006), vol. 40, pages 313 - 325
    - HAYAT, M.A., Methods of Cancer Diagnosis, Therapy and Prognosis, SPRINGER, (2009), vol. 3
    - COLLINS-BUROW ET AL., "Rituximab and its Role as Maintenance Therapy in non-Hodgkin Lymphoma", EXPERT REV ANTICANCER THER, (2007), vol. 7, no. 3, pages 257 - 73
    - MARCUS ET AL., "The Therapeutic Use of Rituximab in non-Hodgkin's Lymphoma", EUR J HAEMOTAL, (2007), vol. 67, pages 5 - 14
    - RIVERA ET AL., NAT. MED., (1996), vol. 2, pages 1028 - 32
    - NO ET AL., PROC. NATL. ACAD. SCI. USA, (1996), vol. 93, pages 3346 - 51
    - GOSSEN; BUJARD, PROC. NATL. ACAD. SCI. USA, (1992), vol. 89, pages 5547 - 51
    - POLLOCK ET AL., PROC. NATL. ACAD. SCI. USA, (2000), vol. 97, pages 13221 - 26
    - RIVERA ET AL., PROC. NATL. ACAD. SCI. USA, (1999), vol. 96, pages 8657 - 62
    - PENG ET AL., "Viral Vector Targeting", CURR. OPIN BIOTECHNOL., (1999), vol. 10, pages 454 - 457
    - GUNZBURG ET AL., "Retroviral Vector Targeting for Gene Therapy", CYTOKINES MOL. THER., (1996), vol. 2, pages 177 - 184
    - WICKHAM, "Targeting Adenovirus", GENE THER., (2000), vol. 7, pages 110 - 114
    - DACHS ET AL., "Targeting Gene Therapy to Cancer: A Review", ONCOL. RES., (1997), vol. 9, pages 313 - 325
    - CURIEL, "Strategies to Adapt Adenoviral Vectors for Targeted Delivery", ANN NY ACAD. SCI., (1999), vol. 886, page 158171
    - FINDEIS ET AL., "Targeted Delivery of DNA for Gene Therapy via Receptors", TRENDS BIOTECHNOL., (1993), vol. 1, page 202205
    - CRISTIANO ET AL., "Strategies to Accomplish Gene Delivery Via the Receptor-Mediated Endocytosis Pathway", CANCER GENE THER., vol. 3, no. 1, pages 49 - 57
    - S. C. PHILIPS, "Receptor-Mediated DNA Deliver Approaches to Human Gene Therapy", BIOLOGICALS, (199503), vol. 23, no. 1, pages 13 - 6
    - MICHAEL ET AL., "Strategies to Achieve Targeted Gene Delivery Via the Receptor-Mediated Endocytosis Pathway", GENE THER., (199407), vol. 1, no. 4, pages 223 - 32
    - LIN ET AL., "Antiangiogenic Gene Therapy Targeting The Endothelium-Specific Receptor Tyrosine Kinase Tie2", PROC. NATL. ACAD. SCI., USA, (1998), vol. 95, pages 8829 - 8834
    - SUDIMACK ET AL., "Targeted Drug Delivery Via the Folate Receptor", ADV. DRUG DELIV., (200003), pages 147 - 62
    - FAN, "Therapeutic Application of Anti-Growth Factor Receptor Antibodies", CURR. OPIN. ONCOL., (199801), vol. 10, no. 1, pages 67 - 73
    - WADHWA ET AL., "Receptor Mediated Glycotargeting", J. DRUG TARGET, (1995), vol. 3, no. 2, pages 111 - 27
    - PERALES ET AL., "An Evaluation of Receptor-Mediated Gene Transfer Using Synthetic DNA-Ligand Complexes", EUR. J. BIOCHEM, (199412), vol. 1, no. 2, pages 226,255 - 66
    - SMITH ET AL., "Hepatocyte Directed Gene Delivery by Receptor-Mediated Endocytosis", SEMIN LIVER DIS., (1999), vol. 19, no. 1, pages 83 - 92
    - KUROKI ET AL., "Specific Targeting Strategies of Cancer Gene Therapy Using a Single-Chain Variable Fragment (scFv) with a High Affinity for CEA", ANTICANCER RES., (2000), pages 4067 - 71
    - JIANG ET AL., "In Vivo Cell Type-Specific Gene Deiivery With Retroviral Vectors That Display Single Chain Antibodies", GENE THER., (1999), vol. 6, pages 1982 - 7
    - ENGELSTADTER ET AL., "Targeting Human T Cells By Retroviral Vectors Displaying Antibody Domains Selected From A Phage Display Library", HUM. GENE THER., (2000), vol. 11, pages 293 - 303
    - JIANG, "Cell-Type-Specific Gene Transfer Into Human Cells With. Retroviral Vectors That Display Single-Chain Antibodies", J. VIROL., (1998), vol. 72, pages 10148 - 56
    - CHU ET AL., "Toward Highly Efficient Cell-Type-Specific Gene Transfer With Retroviral Vectors Displaying Single-Chain Antibodies", J. VIROL, (1997), vol. 71, pages 720 - 5
    - CHU ET AL., "Retroviral Vector Particles Displaying The Antigen-Binding Site Of An Antibody Enable Cell-Type-Specific Gene Transfer", J. VIROL, (1995), vol. 69, pages 2659 - 63
    - CHU ET AL., "Cell Targeting With Retroviral Vector Particles Containing Antibody-Envelope Fusion Proteins", GENE THER., (1994), vol. 1, pages 292 - 9
    - LOPEZ-GUILLERMO, A. ET AL., J CLIN ONCOL, (1994), vol. 12, pages 1343 - 1348
    - SOLAL-CELIGNY ET AL., BLOOD, (2004), vol. 104, pages 1258 - 1265
    - RUCZINSKI, 1., J. OF COMPUTATIONAL AND GRAPHICAL STATISTICS, (2003), vol. 12, pages 475 - 511
    - FRIEDMAN, J. H., "Regularized Discriminant Analysis", JASA, (1989), vol. 84, pages 165 - 175
    - BREIMAN, L., RANDOM FORESTS, MACHINE LEARNING, (2001), vol. 45, pages 5 - 32
    - PEPE, M. S., THE STATISTICAL EVALUATION OF MEDICAL TESTS FOR CLASSIFICATION AND PREDICTION, (2003), vol. 28
    - ZWEIG, M. H.; CAMPBELL, G., CLIN. CHEM., (1993), vol. 39, pages 561 - 577
    - URQUHART ET AL., ANN. REV. PHARMACOL. TOXICOL., (1984), vol. 24, pages 199 - 236
    - WANG ET AL., BIOCHEM. BIOPHYS. RES. COMMUN., (1987), vol. 147, pages 980 - 985
    - ZHOU, JOURNAL OF CONTROLLED RELEASE, (1992), vol. 19, pages 269 - 274
    - HU, S.T.P.PHARMA. SCI., (1994), vol. 4, no. 6, page 466
    - ALLEN ET AL., FEBS LETTERS, (1987), vol. 223, page 42
    - WU ET AL., CANCER RESEARCH, (1993), vol. 53, page 3765
    - PAPAHADJOPOULOS ET AL., ANN. N.Y. ACAD. SCI., (1987), vol. 507, page 64
    - GABIZON ET AL., PNAS, (1988), vol. 85, page 6949
    - KLIBANOV ET AL., FEBS LETT., (1990), vol. 268, page 235
    - SUNAMOTO ET AL., BULL. CHEM. SOC. JPN., (1980), vol. 53, page 2778
    - ILIUM ET AL., FEBS LETT., (1984), vol. 167, page 79
    - BLUME ET AL., BIOCHIMICA ET BIOPHYSICA ACTA, (1990), vol. 1029, page 91
    - IDSON, Pharmaceutical Dosage Forms, MARCEL DEKKER, INC., (1988), vol. 1, page 199
    - ROSOFF, Pharmaceutical Dosage Forms, MARCEL DEKKER, INC., (1988), vol. 1, page 245
    - LIEBERMAN, RIEGER AND BANKER, Block in Pharmaceutical Dosage Forms, MARCEL DEKKER, INC., (1988), vol. 2, page 199,245,
    - HIGUCHI ET AL., Remington's Pharmaceutical Sciences, MACK PUBLISHING CO., (1985), page 301
    - LEUNG; SHAH, Controlled Release of Drugs: Polymers and Aggregate Systems, VCH PUBLISHERS, (1989), pages 185 - 215
    - SCHOTT, Remington's Pharmaceutical Sciences, MACK PUBLISHING CO., (1985), page 271
    - CONSTANTINIDES ET AL., PHARMACEUTICAL RESEARCH, (1994), vol. 11, pages 1385 - 1390
    - RITSCHEL, METH. FIND. EXP. CLIN. PHARMACOL., (1993), vol. 13, page 205
    - HO ET AL., J. PHARM. SCI., (1996), vol. 85, pages 138 - 143
    - LEE ET AL., CRITICAL REVIEWS IN THERAPEUTIC DRUG CARRIER SYSTEMS, (1991), page 92
    - TAKAHASHI ET AL., J. PHARM. PHARMACOL., (1988), vol. 40, page 252
    - MURANISHI, CRITICAL REVIEWS IN THERAPEUTIC DRUG CARRIER SYSTEMS, (1990), vol. 7, pages 1 - 33
    - EL HARIRI ET AL., J. PHARM. PHARMACOL., (1992), vol. 44, pages 651 - 654
    - BRUNTON ET AL., The Pharmacological Basis of Therapeutics, 9th Ed.,, MCGRAW-HILL, (1996), pages 934 - 935
    - SWINYARD, Remington's Pharmaceutical Sciences, MACK PUBLISHING CO., (1990), pages 782 - 783
    - YAMAMOTO ET AL., J. PHARM. EXP. THER., (1992), vol. 263, page 25
    - YAMASHITA ET AL., J. PHARM. SCI., (1990), vol. 79, pages 579 - 583
    - JARRETT, J., CHROMATOGR., (1993), vol. 618, pages 315 - 339
    - BUUR ET AL., J. CONTROL PEL., (1990), vol. 14, pages 43 - 51
    - HASHAM; TSYGANKOV, VIROLOGY, (2004), vol. 320, pages 313 - 329
    - MURAMATSU ET AL., CELL, (2000), vol. 102, pages 553 - 63
    - NAKAMURA, M. ET AL., INT. IMMUNOL., (1996), vol. 8, pages 193 - 201
    - OKAZAKI ET AL., J EXP MED., (2003), vol. 197, no. 9, pages 1173 - 81
    - IMMUNOL, (2005), vol. 174, no. 10, pages 6477 - 89
    - LEUKEMIA, NN, vol. 24, no. 11, pages 1859 - 66
    - ANN NY ACAD SCI, (2007), vol. 1103, pages 90 - 3
    - WOO ET AL., ONCOGENE, (2007), vol. 26, no. 41, pages 6010 - 20
    - BIOINFORMATICS, (2009), vol. 25, no. 14, pages 1754 - 60
    - DCANS ET AL., EMBO J, (2000), vol. 19, pages 6675 - 6685
    - ANDREWS ET AL., J EXP MED, (1978), vol. 148, pages 1198 - 215
    - DIXON ET AL., ARTHRITIS RHEUM, (1978), vol. 21, pages 64 - 7
    - IZUI ET AL., INT REV IMMUNOL, (2000), vol. 19, pages 447 - 72
    - MCPHEE ET AL., J IMMUNOL, (2011), vol. 187, pages 4695 - 4704
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.